Serologic testing of randomly selected children after hepatitis B vaccination: a cross-sectional population-based study in Lao People’s Democratic Republic

Abstract

Background Population immunity against hepatitis B virus (HBV) in Lao People’s Demographic Republic (PDR) has not been examined since the national HBV vaccination program was started in 2002. Vaccine has been observed to be frozen at times during cold-chain transport in vaccination programs in Lao PDR and other developing countries, which will inactivate the vaccine. Therefore, this study used post-vaccination serologic testing to evaluate the effects of HBV immunization in Lao PDR. Methods A cross-sectional serologic study was conducted among children (age range, 5–9 years) and mothers (15–45 years) who were randomly selected using probability-proportional-to-size sampling from central Lao PDR. Blood samples were collected as dried blood spots (DBS) and analyzed using chemiluminescent microparticle immunoassay to detect anti-hepatitis B surface (HBs) titers. We also evaluated the correlation between anti-HBs levels measured in DBS and serum among healthy healthcare workers in Vientiane. Results Anti-HBs titers from DBS were strongly correlated with serum levels (correlation coefficient = 0.999) in all 12 healthcare workers evaluated. A linear regression model showed that 10 mIU/mL of serum anti-HBs was equivalent to 3.45 mIU/mL (95% CI: 3.06–3.85) of DBS. Among 911 mother-child pairs tested, 171 children had documentation of vaccination. Of the 147 children who had received ≥3 doses of the hepatitis B vaccine, 1 (0.7%) was positive for anti-HBs. The remaining 24 children received the hepatitis B vaccine only twice, once or no dose. Conclusions The results showed extremely low positivity for anti-HBs among vaccinated children in central Lao PDR. Therefore, post-vaccination serologic testing is important to evaluate population immunity against HBV infection. DBS testing is a potential low-cost tool to evaluating the effectiveness of HBV vaccination programs.

Seroconversion of Hepatitis B Vaccine in Young Bangladeshi Children: A Tertiary Centre Experience

“…A study from South Korea and Japan was found anti-HBs titres in 50% children were seronegative by 7 years and zero by 13 years. They recommend one booster dose if post vaccination screening is suggestive at the age of 12 -14 years [18] [24]. A beautiful systematic review and meta-analysis from 12 countries was done by Pakistan.…”

Analyses of blood donor samples from eight provinces in Lao PDR suggest considerable variation concerning HBV exposure and carriage

“…The lack of HBV surveillance and limited access to testing undermine efforts to assess HBV treatment and disease burden in the whole country. In recent years, studies investigated the prevalence of chronic infection among mothers and their children as well as protection levels due to vaccination [12,[17][18][19][20].…”

Vaccine temperature management in Lao People's Democratic Republic: A nationwide cross-sectional study

“…The country suffered several outbreaks of vaccine-preventable diseases, such as diphtheria and measles, despite improved vaccination coverage (14-17). Some studies reported that seroprevalence or seroprotection rates of these diseases were low (14-16) (19).…”

“…Proposed explanations included a low immunization coverage, reduced response to vaccines in individuals due to immune deficiencies, suboptimal nutritional status, and parasite infestation (14) (16) (18) (19). In addition, some authors also suggested that challenges in cold chain management might have affected vaccine effectiveness (14-16) (18) (19).…”